文献速递甲状腺疾病

所有N1b中高危甲状腺乳头状癌患者都需要全甲状腺切除和辅助放射性碘治疗吗?

Are Total Thyroidectomy and Adjuvant Radioactive Iodine Treatment Required in All Patients with N1b Intermediate-High Risk Papillary Thyroid Carcinoma?
PubMed 文献 · Thyroid · 2025-12-04

该多中心回顾性队列研究纳入593例cT1-3N1bM0甲状腺乳头状癌患者,比较腺叶切除、全甲状腺切除及全甲状腺切除联合RAI三组的肿瘤学结局。中位随访71.5个月,三组无复发生存(p=0.19)和疾病特异性生存(p=0.40)均无显著差异;多因素分析显示年龄、原发肿瘤大小、转移淋巴结大小和淋巴结外侵犯与更短RFS独立相关。结论提示RAI可能对部分广泛淋巴结病变患者改善RFS,但所有cN1b患者常规使用RAI可能不必要。

要点

  • cN1b中危PTC患者中,腺叶切除、全甲状腺切除及全甲状腺切除联合RAI三组RFS和DSS无显著差异。
  • 年龄、原发肿瘤大小、转移淋巴结大小及淋巴结外侵犯是RFS的独立危险因素。
  • RAI可能对部分广泛淋巴结病变患者改善RFS,但所有cN1b患者常规使用可能不必要。

核心结论

  • 在cN1b中危PTC患者中,腺叶切除、全甲状腺切除及全甲状腺切除联合RAI三组间RFS和DSS无显著差异。
  • RAI可能对部分广泛淋巴结病变患者改善RFS,但所有cN1b患者常规使用RAI可能不必要。
  • 腺叶切除或全甲状腺切除不联合RAI可能是较低危cN1b患者的合适选择。

研究设计与样本

  • 多中心回顾性队列研究,纳入2010至2022年间接受甲状腺切除联合治疗性侧颈淋巴结清扫的cT1-3N1bM0 PTC患者。
  • 共纳入593例患者(女性60.6%,中位年龄58.0岁),中位随访71.5个月。
  • 比较腺叶切除联合侧颈清扫、全甲状腺切除联合侧颈清扫、全甲状腺切除联合侧颈清扫后辅助RAI三组的RFS和DSS。

主要发现

  • 三组间RFS无显著差异(p=0.19),DSS亦无显著差异(p=0.40)。
  • 全甲状腺切除联合RAI组RFS有更差趋势,但无统计学意义(p=0.19)。
  • 多因素分析显示,年龄较大(HR 1.024/年,CI 1.007-1.041,p=0.006)与更短RFS独立相关。
  • 原发肿瘤较大(HR 1.026/mm,CI 1.012-1.041,p<0.001)与更短RFS独立相关。
  • 转移淋巴结较大(HR 1.020/mm,CI 1.003-1.036,p=0.017)及淋巴结外侵犯(HR 1.741,CI 1.046-2.898,p=0.033)与更短RFS独立相关。

临床怎么用

  • 对于较低危cN1b PTC患者,腺叶切除或全甲状腺切除不联合RAI可能是合适选择。
  • RAI可能考虑用于部分广泛淋巴结病变患者以改善RFS,但不应常规用于所有cN1b患者。
  • 年龄、原发肿瘤大小、转移淋巴结大小和淋巴结外侵犯可用于识别RFS较短的高危患者。

局限性

  • 本研究为回顾性队列研究,可能存在选择偏倚。
  • 原文未报告其他局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The optimal extent of surgery and the role of radioactive iodine (RAI) in patients with papillary thyroid carcinoma (PTC) with lateral neck metastasis (cN1b) remain controversial. We aimed to evaluate the oncologic outcomes of lobectomy with lateral neck dissection, total thyroidectomy with lateral neck dissection, and total thyroidectomy with lateral neck dissection followed by adjuvant RAI in patients with intermediate-risk cN1b PTC. METHODS: In this multicenter retrospective cohort study, we included patients with cT1-3N1bM0 PTC who underwent thyroidectomy with therapeutic lateral neck dissection between 2010 and 2022. Recurrence-free survival (RFS) and disease-specific survival (DSS) were compared across three treatment groups using Kaplan-Meier. Multivariable cox proportional hazards models were also used to identify independent risk factors for recurrence. RESULTS: We included 593 patients (60.6% female; median age, 58.0 years) who had a median follow-up duration of 71.5 months. We observed no significant differences in RFS (p = 0.19) or DSS (p = 0.40) among the treatment groups of lobectomy, total thyroidectomy, and total thyroidectomy with RAI. Although the total thyroidectomy with RAI group showed a trend toward worse RFS, this was not statistically significant (p = 0.19). In multivariable analysis, older age (hazard ratio [HR] 1.024 per year, confidence interval [CI] 1.007-1.041, p = 0.006), larger primary tumor size (HR 1.026 per mm, CI 1.012-1.041, p < 0.001), larger metastatic lymph node size (HR 1.020 per mm, CI 1.003-1.036, p = 0.017), and extranodal extension (HR 1.741, CI 1.046-2.898, p = 0.033) were independently associated with shorter RFS. CONCLUSIONS: RAI may improve RFS in selected patients with extensive nodal disease, but its routine use in all cN1b PTC cases may be unnecessary. Lobectomy or total thyroidectomy without RAI could be appropriate options in lower risk cN1b patients. Further studies are warranted to refine treatment strategies in intermediate-risk cN1b PTC.

来源:Thyroid,查看原文。版权归原作者所有。

引用

  1. Fujiwara T, Kofuji N, Kishimoto Y, et al. Are Total Thyroidectomy and Adjuvant Radioactive Iodine Treatment Required in All Patients with N1b Intermediate-High Risk Papillary Thyroid Carcinoma? Thyroid. 2025. PMID: 41371750. doi:10.1177/10507256251401241

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。